NU‑9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone
March 30, 2022
A paper has recently been published demonstrating that AKV9 improves the health of mutant SOD1 mouse upper motor neurons in vitro much better than the FDA-approved ALS drugs riluzole and edaravone, and the combination of AKV9 with either of those drugs provides an additive effect.
Read More
AKAVA Founder, Richard B. Silverman receives 2021 Tetrahedron Prize
August 30, 2021
Our Founder, Richard B. Silverman, was selected to receive the 2021 Tetrahedron Prize for Creativity in Organic Chemistry and will present a lecture at the Tetrahedron Symposium in Lisbon, Portugal this June.
Read More